DM0000: The mark consists of The stylized term "NALPROPION" with a capital "N". To the left of NALPROPION is a stylized logo comprised of two curved, triangular shapes strategically placed so as to form the outline of the letter "N". Underneath the term "NALPROPION" is the stylized word "PHARMACEUTICALS" in all capital letters.
GS0051: Pharmaceutical preparations for use in the treatment of obesity and inducing weight loss
CC0000: Color is not claimed as a feature of the mark.
DS0000: "PHARMACEUTICALS"
Case File Event Statements
7/23/2018 - 6 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
7/24/2018 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
10/3/2018 - 6 years ago
4 - ASSIGNED TO EXAMINERType:DOCK
10/9/2018 - 6 years ago
5 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
7/25/2018 - 6 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILEDType:MDSC
11/20/2018 - 6 years ago
7 - PUBLISHED FOR OPPOSITIONType:PUBO
1/22/2019 - 5 years ago
12 - USE AMENDMENT FILEDType:IUAF
2/12/2019 - 5 years ago
11 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU
2/12/2019 - 5 years ago
13 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
3/15/2019 - 5 years ago
14 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTEDType:CNPR
3/16/2019 - 5 years ago
15 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILEDType:SUNA
4/23/2019 - 5 years ago
16 - REGISTERED-PRINCIPAL REGISTERType:R.PR
10/23/2019 - 5 years ago
17 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIPType:ASGN
10/31/2018 - 6 years ago
6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
11/20/2018 - 6 years ago
8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
1/15/2019 - 5 years ago
9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
1/22/2019 - 5 years ago
10 - TEAS STATEMENT OF USE RECEIVEDType:EISU
7/27/2021 - 3 years ago
19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVEDType:REAP